Brief Summary

Provide pre-approval single patient Expanded Access (compassionate use) of Ritlecitinib for patients.

Detailed Description

Expanded Access requests from treating physicians may be submitted at www.pfizercares.com;

availability will depend on location/country.

Status
Available
EA Type
Individual Patients
Conditions
Alopecia Areata
Interventions

Drug: Ritlecitinib
capsules

Eligibility Criteria

Must have ≥ 50% hair loss on scalp due to Alopecia Areata (AA) and be intolerant or have
inadequate response to all commonly used AA therapies accessible in the country. Additional
eligibility criteria may be required.

Eligibility Gender
All
Eligibility Age
Minimum: 12 Years
Contacts

Pfizer Cares
PfizerCares@Pfizer.com

Sponsors / Collaborators
Pfizer
In Expanded Access, treating physicians are the Sponsors
NCT Number
NCT05522556
Keywords
Alopecia Areata (AA)
Alopecia
Patchy AA
Alopecia Universalis (AU)
Alopecia Totalis (AT)
Ophiasis
Eyelash Loss
Eyebrow Loss
Hair Loss
MeSH Terms
Alopecia
Alopecia Areata